27011200 25904246 36217339 23726825 24081122 22905251 33704184 27512666 22516053 26898708 27901484 28215147 27933316 31262361 24067362 32722005 31936317 28345022 35598646 - Search Results

Year	Number of Results
2012	2
2013	3
2015	2
2016	4
2017	3
2019	1
2020	3
2022	2
2023	0

1

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies.

Villa NY, Rahman MM, McFadden G, Cogle CR. Villa NY, et al. Viruses. 2016 Mar 22;8(3):85. doi: 10.3390/v8030085. Viruses. 2016. PMID: 27011200 Free PMC article. Review.

2

Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells.

Villa NY, Wasserfall CH, Meacham AM, Wise E, Chan W, Wingard JR, McFadden G, Cogle CR. Villa NY, et al. Blood. 2015 Jun 11;125(24):3778-88. doi: 10.1182/blood-2014-07-587329. Epub 2015 Apr 22. Blood. 2015. PMID: 25904246 Free PMC article.

3

Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases.

Vorobyev PO, Babaeva FE, Panova AV, Shakiba J, Kravchenko SK, Soboleva AV, Lipatova AV. Vorobyev PO, et al. Mol Biol. 2022;56(5):684-695. doi: 10.1134/S0026893322050144. Epub 2022 Oct 5. Mol Biol. 2022. PMID: 36217339 Free PMC article.

4

Oncolytic myxoma virus: the path to clinic.

Chan WM, Rahman MM, McFadden G. Chan WM, et al. Vaccine. 2013 Sep 6;31(39):4252-8. doi: 10.1016/j.vaccine.2013.05.056. Epub 2013 May 29. Vaccine. 2013. PMID: 23726825 Free PMC article. Review.

5

Panorama from the oncolytic virotherapy summit.

Pol JG, Marguerie M, Arulanandam R, Bell JC, Lichty BD. Pol JG, et al. Mol Ther. 2013 Oct;21(10):1814-8. doi: 10.1038/mt.2013.207. Mol Ther. 2013. PMID: 24081122 Free PMC article. No abstract available.

6

Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells.

Bartee E, Meacham A, Wise E, Cogle CR, McFadden G. Bartee E, et al. PLoS One. 2012;7(8):e43298. doi: 10.1371/journal.pone.0043298. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22905251 Free PMC article.

7

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs.

Innao V, Rizzo V, Allegra AG, Musolino C, Allegra A. Innao V, et al. Curr Oncol. 2020 Dec 25;28(1):159-183. doi: 10.3390/curroncol28010019. Curr Oncol. 2020. PMID: 33704184 Free PMC article. Review.

8

The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications.

Tsang JJ, Atkins HL. Tsang JJ, et al. Oncolytic Virother. 2015 Jan 23;4:13-23. doi: 10.2147/OV.S45525. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512666 Free PMC article. Review.

9

Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.

Bartee E, Chan WM, Moreb JS, Cogle CR, McFadden G. Bartee E, et al. Biol Blood Marrow Transplant. 2012 Oct;18(10):1540-51. doi: 10.1016/j.bbmt.2012.04.004. Epub 2012 Apr 16. Biol Blood Marrow Transplant. 2012. PMID: 22516053 Free PMC article.

10

Chemosensitizing AML cells by targeting bone marrow endothelial cells.

Bosse RC, Wasserstrom B, Meacham A, Wise E, Drusbosky L, Walter GA, Chaplin DJ, Siemann DW, Purich DL, Cogle CR. Bosse RC, et al. Exp Hematol. 2016 May;44(5):363-377.e5. doi: 10.1016/j.exphem.2016.02.003. Epub 2016 Feb 16. Exp Hematol. 2016. PMID: 26898708 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year